SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-19-003166
Filing Date
2019-05-03
Accepted
2019-05-03 16:02:37
Documents
54
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 p42919010q.htm 10-Q 323227
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 8625
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 8659
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4710
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4739
  Complete submission text file 0001214659-19-003166.txt   2177383

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE hgen-20190331.xml EX-101.INS 272983
7 XBRL SCHEMA FILE hgen-20190331.xsd EX-101.SCH 38808
8 XBRL CALCULATION FILE hgen-20190331_cal.xml EX-101.CAL 37658
9 XBRL DEFINITION FILE hgen-20190331_def.xml EX-101.DEF 124282
10 XBRL LABEL FILE hgen-20190331_lab.xml EX-101.LAB 265909
11 XBRL PRESENTATION FILE hgen-20190331_pre.xml EX-101.PRE 190672
Mailing Address 533 AIRPORT BLVD. SUITE 200 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 200 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 19796060
SIC: 2834 Pharmaceutical Preparations